On This Page:
Abstracts and related information submitted to the Alzheimer's Association International Conference® (AAIC®) meetings are considered final and confidential from the time of submission. This Confidentiality Agreement covers all abstracts, title of abstract and summary description placeholders ("Confidential Information"). Compliance with the Confidentiality Agreement is required by all parties receiving Confidential Information, which includes all embargoed or early copies of the abstracts shared with news media, as these documents are confidential per this policy and each recipient will be held accountable for any violations of AAIC's Confidentiality Agreement and Embargo Policy.
Prior to the Confidential Information being publicly released by the Alzheimer's Association in conjunction with the AAIC, authors, coauthors, sponsors of the research, news media, journalists, analysts, other AAIC attendees and recipients of Confidential Information may not:
For a study to be eligible for acceptance into the AAIC, information contained in the abstract, as well as additional data and information to be presented about the study at AAIC, must not be disclosed before the findings have been publicly released in conjunction with AAIC.
Unless express permission is granted by the Alzheimer's Association in its discretion, which may be obtained directly upon request, the contents and conclusions of the abstract must not be presented at any scientific, medical or educational meeting or published in a scientific, medical or educational publication (in any medium) in whole or in part, before AAIC. If attendees wish to have information from an abstract or portions of the dataset disclosed in advance of public release in conjunction with AAIC, specific exception requests must be made per the Confidentiality Agreement Exception instructions described below.
Alzheimer's Association recognizes that certain federal and international laws require disclosure of certain clinical trial results through federal and international registries within a certain time period. If the imposed deadline for data submission falls before AAIC meeting dates, submission of the trial results to the required registry will not be viewed as a breach of AAIC's Confidentiality Agreement.
Confidentiality Agreement Exceptions
Exceptions to the AAIC Confidentiality Agreement require communication with Alzheimer's Association a minimum of 48 hours in advance of any public release. Specific inquiries about exceptions to the AAIC Confidentiality Agreement should be emailed to AAICConfidentiality@alz.org.
A Securities and Exchange Commission ("SEC") Exception is available to companies whose securities are publicly traded to the extent that disclosure is necessary for that company to comply with the disclosure requirements under any US federal or state or international securities laws.
The obligations above shall not extend to any part of the Confidential Information (a) that can be demonstrated to have been in the public domain or publicly known at the time of disclosure; (b) that becomes part of the public domain or publicly known by publication or otherwise, not due to any unauthorized act by the abstract submitter; (c) that can be demonstrated as independently developed by the abstract submitter without reference to or reliance upon such Confidential Information; or (d) that is required to be disclosed by law, in which case the abstract submitter will notify the Alzheimer's Association of such requirement.
Other Exceptions to the AAIC Confidentiality Agreement may be granted by the Alzheimer's Association in specific circumstances including but not limited to public health reasons and/or to meet the requirements of state, national or international government agencies.
No matter if a Confidentiality Agreement Exception applies or is granted, Alzheimer's Association retains the right, in its sole discretion, to change an abstract's placement in the meeting program based on the extent of information disclosed. If an exception applies or is granted, the study will most likely be ineligible for the official AAIC news program.
If the Confidentiality Agreement and Embargo Policy is broken, the Alzheimer's Association retains the right, in its sole discretion, to: remove the abstract from AAIC, deny the responsible author(s) attendance at AAIC, and/or bar the responsible author(s) from future submission and/or attendance at AAIC.
Audio and video recording are prohibited in the AAIC Exhibit Hall, poster area and all session rooms.
Photographs: Please respect speaker instructions in regards to the taking of photos during their presentation. Do not capture or share details of any unpublished data presented at the meeting.
If a speaker has indicated he/she is open to photography, please use common courtesy and do not behave in a manner that is disruptive or distracting, either to the speaker or to your fellow audience members.
Because of the proprietary nature of data and the reporting of preliminary, unpublished research findings, the dissemination or reproduction of someone else’s slides, poster(s), audio or data before, during or after AAIC is strictly prohibited.
Sharing your experience on social media is encouraged to add to the discussion and excitement of AAIC, as long as it complies with AAIC embargo and confidentiality rules. Sharing of images on social media that contain discernable research data is prohibited.
Violation of the above restrictions may result in appropriate penalty, including removal from AAIC, and denial of entry to future AAICs.
Please direct questions regarding this policy to firstname.lastname@example.org.
Credentialed reporters should register with the Alzheimer’s Association media relations department, and follow the policies outlined by AAIC media relations guidelines published on the AAIC website.
Cancellation and refund requests must be received by June 14, 2019. A receipt of your registration is required for the cancellation request to be processed. After June 14, no refunds will be issued for cancellations of any type, including no shows. All refunds will be subject to a $100 USD administrative fee. Email requests to AAIC@experient-inc.com
To provide all AAIC® attendees an optimal learning environment, only those age 18 and older are able to enter session rooms, receptions, exhibit hall and any other general conference areas due to the sensitivity of presentations and for the courtesy of other attendees. Please keep these age requirements in mind when planning your trip. If you require daycare, please inquire with your hotel concierge for a list of approved providers.
For nursing mothers, room 405 in the Los Angeles Convention Center has been reserved for your privacy throughout the conference. The room is located on the second floor and will be available during the duration of the conference. The room will be equipped with chairs and tables in private areas for changing diapers or nursing, as well as electricity and a water cooler (room temperature) and refrigeration. Parents and guardians are responsible for providing infant care supplies. The infant care room will be unsupervised. AAIC will not be responsible for accidents or injuries that may occur in this room.
The Alzheimer's Association International Conference® (AAIC®) is a well-recognized, global platform for news regarding advances in Alzheimer's and dementia research. If you are interested in having the research you present at AAIC eligible for inclusion in AAIC news releases and news conferences, it must not be published (online or hard copy) or presented, in whole or in part, in any manner, previous to presentation at AAIC. (Note: The Association reserves the right to also include previously published material in its news program, if it so chooses, but this is generally not the case.)
All materials submitted to AAIC are embargoed for publication and broadcast until the officially scheduled date and time of presentation at AAIC, unless the Alzheimer's Association provides written notice of change of date and/or time in advance, such as on an AAIC news release. If there are questions, please contact the Alzheimer’s Association Public Relations Department at email@example.com.
Public and news announcements made in advance of AAIC that a scientist or company is scheduled to make a presentation at AAIC may include the date, time, location and topic of presentation, but may not include the methods, results and/or conclusions, nor the type or direction of results, even if that is included in the name/title of the submitted abstract. For that reason, authors are discouraged from putting the type and/or direction of results in the abstract title.
All news media representatives, scientists and their funders, and exhibitors/sponsors agree to honor the news embargoes and release times stated on news releases and other news materials issued by the Alzheimer's Association/AAIC. If a reporter or news media outlet breaks an AAIC news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events.
If a scientist or company that is a participant in an AAIC news briefing or news release is discovered to have broken the news embargo, or encouraged the breaking of a news embargo, the Alzheimer's Association reserves the right to remove the participant from the news briefing and remove that scientist's/company's information from the news release. In addition, consequences for violation of the news embargo may include retraction of the accepted abstract from AAIC and/or loss of privileges of presenting research at AAIC in the future.
If a publicly traded company is advised that it is legally required to disclose certain data or other information from a confidential AAIC abstract in advance of the AAIC news embargo to satisfy requirements of the U.S. Securities and Exchange Commission or a corresponding regulatory body in a country where the company’s stock is traded (collectively, “SEC”), that company must submit to AAIC, in advance of the SEC-required disclosure:
If this is done, the abstract will not be automatically rejected or removed from AAIC on the basis of the SEC-required release of data or other information, though the situation is still subject to AAIC review. At a minimum, AAIC may in its discretion change the position of the abstract in AAIC, e.g., from oral presentation to poster. The abstract will most likely be ineligible for the AAIC news program.
The company may issue a news release at the time of SEC-required disclosure. The AAIC abstract itself may not be released publicly by the company or lead author. Mention may be made that full details will be presented at AAIC. AAIC would prefer that the news release:
As an example, a statement that a study “met its primary endpoint of improving cognition” is qualitative, while “ADAS-Cog scores remained stable for 18 months in the treated group” would be considered quantitative. A quote such as “We are encouraged by these promising results” would not be viewed as interpretive, while a quote such as “These findings support [drug] as first line therapy in mild to moderate Alzheimer’s” would be seen as an interpretation of the data.
Members of this professional society stay connected to the field through exclusive member benefits and programs. Join for just $30* at the Alzheimer's Association (Booth 500).
*Offer available onsite at AAIC (through 7/18/19). Applies only to registrants who paid the non-member fee.
Learn the basics or brush up on your skills by attending an AAIC preconference or educational workshop. These events provide the opportunity to explore the newest findings and practices for the prevention and treatment of Alzheimer's disease and other dementias.